Group 2:TACE

3 trials

Sponsors

Affiliated Tumor Hospital of Guangxi Medical University, Hepatobiliary Surgery Department,Shanghai Public Health Clinical Center

Conditions

HCChepatocellular carcinoma

Phase 2

TACE+radiotherapy versus TACE in down-staging of non-surgical locally hepatocellular carcinoma before liver resection: A clinical prospective, randomized controlled, phase II trial (GX-HCC-001)

RecruitingChiCTR1800018000

Affiliated Tumor Hospital of Guangxi Medical UniversityHCC

Start: 2018-08-26Updated: 2018-09-03

Phase 3

TACE+Radiotherapy versus TACE alone for non-surgical locally hepatocellular carcinoma: A randomized controlled, phase III trial

RecruitingChiCTR1800017438

Affiliated Tumor Hospital of Guangxi Medical UniversityHCC

Start: 2018-08-01Updated: 2018-08-20

Unknown Phase

PD-1 inhibitor combind with TACE as a adjavant therapy for high recurrent risk HCC: a open label, non randomized controlled study.

RecruitingChiCTR2100043153

Hepatobiliary Surgery Department,Shanghai Public Health Clinical Centerhepatocellular carcinoma

Start: 2021-03-01Updated: 2021-05-24